|
14-member ring, the taxane. Unlike the vinca alkaloids, which cause microtubular disassembly, the taxanes promote microtubular assembly and stability, therefore blocking the cell cycle in mitosis. Docetaxel is more potent than paclitaxel in enhancing microtubular assembly and also induces apoptosis. Camptothecin analogs include irinotecan CPT-11 [Camptosar] ; and topotecan Hycamtin ; . These semisynthetic analogs of the alkaloid camptothecin, derived from the Chinese ornamental tree Camptotheca acuminata, inhibit topoisomerase I and interrupt the elongation phase of DNA replication.
Three agents are currently approved by the U.S. Food and Drug Administration FDA ; in the second-line setting: two cytotoxic chemotherapy agents, docetaxel Taxotere; Sanofi-Aventis, Bridgewater, NJ ; and pemetrexed Alimta; Eli Lilly and Company, Indianapolis, IN ; , and the epidermal growth factor receptor EGFR ; tyrosine kinase inhibitor TKI ; erlotinib Tarceva ; Genentech, Inc., South San Francisco, CA and OSI Pharmaceuticals, Melville, NY ; [912]. These agents were approved based on four phase III trials, and there was some variation among patient characteristics included in the trials Table 1 ; . Erlotinib is also approved for use in the third-line setting. Docetaxel was the first agent approved by the FDA for second-line therapy based on two phase III trials Table 2 ; . The TAX 317 trial initially compared docetaxel at a dose of 100 mg m 2 every 3 weeks with BSC; however, after five treatment-related deaths the trial was amended and the dose of docetaxel was reduced to 75 mg m 2 [10]. That trial revealed a longer time to progression, longer.
1. Vinen er en spotter, sterk drikk volder sti, og hver den som raver av den, blir ikke vis. 2. Den redsel en konge vekker, er som lvens brl; den som gjr ham vred, spiller sitt liv. 3. Det er en re for en mann at han holder sig borte fra trette, men enhver dre viser tenner. 4. Om vinteren vil den late ikke plie, derfor sker han forgjeves efter grde om hsten. 5. Tankene i en manns hjerte er et dypt vann, men en forstandig mann drar det op. 6. Mange mennesker roper hit, hver om sin kjrlighet; men hvem finner vel en trofast mann? 7. Den rettferdige vandrer i ustraffelighet; lykkelige er hans barn efter ham. 8. En konge som sitter p sitt dommersete, sikter og skiller ut alt ondt med sine ine. 9. Hvem kan si: Jeg har renset mitt hjerte, jeg er fri for min synd? 10. To slags vektstener og to slags ml - begge deler er en vederstyggelighet for Herren. 11. Allerede den unge gutt viser ved sine gjerninger om hans ferd vil bli ren og rett. 12. ret som hrer, og iet som ser - Herren har skapt dem begge to. 13. Elsk ikke svn, forat du ikke skal bli fattig! Lukk dine ine op, s fr du brd nok ete. 14. Drlig, drlig! sier kjperen; men nr han gr bort, roser han sig. 15. Det er nok gull og perler i mengde, men kyndige leber er en kostelig ting. 16. Ta hans klr, han har gtt i borgen for en annen, og ta pant av ham for fremmedes skyld! 17. Brd vunnet ved svik smaker mannen stt, men siden blir hans munn full av smsten. 18. Planer fr fremgang ved rdslagning; sk veiledning ogs nr du frer krig.
Docetaxel inn
Licular silicone intubation. Three patients 5 eyes ; required canaliculo DCR with the placement of a silicone tube. In 2 patients 3 eyes ; , the degree of canalicular stenosis was severe enough to require conjunctivo DCR with the placement of a pyrex glass tube. All 10 patients had complete resolution of epiphora immediately after surgery. Four patients continued to receive docetaxel after.
Other factors, which are non-endothelial cell specific, include the cytokines, proteinases, adhesion and junctional molecules [62]. VEGF has been extensively studied and is among the most potent endothelial cell-specific angiogenic factor causing endothelial cell proliferation, migration and tube formation and induces vascular hyperpermeability [6467]. VEGF is secreted by a number of tumour cells and is elevated in RCC. In RCC, VEGF expression correlates with tumour vascularity and may be a significant predictor of outcome [62, 68]. Endothelial cells of tumour vessels have, amongst others, an enhanced expression of two receptors for VEGF, namely VEGFR-1 and VEGFR-2, hence making these potential targets of inhibition for treatments [3, 4]. VEGF increases the expression of tissue factor and thrombomodulin in endothelial cells and thus can affect the hemostasis [64, 69, 70]. VEGF is regulated by several growth factors i.e. MAPKs and P13K ; and oncogenes, at multiple levels [71]. Use of targeted agents to bind VEGF protein or inhibit VEGFR tyrosine kinase, therefore, has a strong rationale in RCC and several small molecule inhibitors of VEGFR TKs have shown substantial clinical activity see below.
Served for the undilute and the dilute prothrombin complex times, the proconvertin time and the prothrombin time are shown in table 1. A single dose of 2.5 mg. Marcumar per kilogram of body weight was administered orally to 11 animals after 48 hours starvation. Food was withheld for five more days. Evidence of anticoagulant activity was detected 12 hours after administration. At that time the proconvertin time was prolonged average, 47 seconds ; , but this hypoconvertinemia was not sufficient to prolong the dilute or undilute prothrombin complex times significantly. The dilute and undilute prothrombin complex times became prolonged after 18 hours, and reached a maximum value on the second day after the administration of the drug. The curve observed for the proconvertin time is similar to the curve observed for the undilute and dilute prothrombin complex times. The prothrombin, however, was decreased between 18 and 24 hours and maximal decreases were observed between the second and third day. The activity evidenced by a prolongation of the and docusate
Of pemetrexed usage when erlotinib available 0.328 Point estimate: 35% High value: 43.75%; low value: 26.25% % of docetaxel usage when erlotinib available Point estimate: 35% High value: 43.75%; low value: 26.25% % of patients receiving second-line therapy Point estimate: 21% High value: 26.25%; low value: 15.75% Percent patients receiving third-line therapy % of second line ; Point estimate: 11% High value: 13.75%; low value: 8.25% Pemetrexed cycles per subject Point estimate: 4 High value: 5; low value: 3 Average surface area Point estimate: 1.76 m2 High value: 2.2; low value: 1.32 Pemetrexed cost per vial Point estimate: , 999 High value: , 498; low value: , 499 Pemetrexed dose mg m2 ; Point estimate: 500 High value: 379; low value: 620 Erlotinib duration of treatment weeks ; Point estimate: 9.6 High value: 12; low value: 7.2 0.324.
Docetaxel in prostate cancer
The results of three randomized trials demonstrate that the sequential use of neoadjuvant docetaxel produces superior clinical and pathological responses in locally advanced breast cancer table 4 and dofetilide.
Synopsis According to a report in the Journal of Clinical Oncology, pegfilgrastim NeulastaTM ; administered in the first and subsequent cycles of chemotherapy reduces the incidence of febrile neutropenia by more than 90%. The phase III study involved 928 breast cancer patients receiving treatment with 100 mg m2 docetaxel every three weeks for up to four cycles. They were randomised to 6 mg Neulasta n 463 ; or placebo n 465 ; onceper-cycle on the day after docetaxel administration for up to four cycles.
Drugs used in the treatment of prostate cancer abarelix alora aminoglutethimide bicalutamide casodex cenestin climara clinagen la 40 conjugated estrogens cytadren delestrogen dep gynogen depo-estradiol docetaxel eligard emcyt esclim esterified estrogens and dok.
The key results of the JMEI trial are presented in Table 3-5. It is worth noting that at one year, 29.7% of the patients in each arm were still alive. Primary efficacy outcome: overall survival The median overall survival was reported as 8.3 months in the pemetrexed arm and 7.9 months in the docetaxel arm. The fixed margin method reported in the submission ; demonstrates that the non-inferiority criterion, using a 95% CI of 1.11 for the hazard ratio of pemetrexed over docetaxel, was not met HR: 0.99, 95% CI: 0.82-1.20, P 0.226 ; . In the original JMEI trial the protocol was designed to test for superiority of pemetrexed over docetaxel; results of this test are not reported in the submission
The project was expected to run from year 2004 -2006, but the activities have not been completed and it's therefore in progress and dolasetron.
SIOUX VALLEY HOSPITAL SOUTH DAKOTA NON-PROFIT CORPORATION ; 1305 W. 18TH STREET SIOUX FALLS, SD 571175039 FOR: MEDICAL TESTING SERVICES IN THE NATURE OF MEDICAL AND HEALTH SCREENING, LABORATORY TESTING AND EVALUATION SERVICES, HEALTH AND WELLNESS ASSESSMENT, AND PROMOTION OF HEALTH AND WELLNESS BY PROVIDING HEALTH RELATED INFORMATION, IN CLASS 44 U.S. CLS. 100 AND 101.
5. De skal frykte dig, s lenge solen er til, og s lenge mnen skinner, fra slekt til slekt. 6. Han skal komme ned som regn p en nysltt eng, lik en regnskur, som vter jorden. 7. I hans dager skal den rettferdige blomstre, og det skal vre megen fred, inntil mnen ikke er mere. 8. Og han skal herske fra hav til hav og fra elven inntil jordens ender. 9. For hans syn skal de som bor i rkenene, bie kne, og hans fiender skal slikke stv. 10. Kongene fra Tarsis og ene skal komme med gaver, kongene fra Sjeba og Seba frembre skatt. 11. Alle konger skal falle ned for ham, alle hedninger skal tjene ham. 12. For han skal frelse den fattige som roper, og den elendige som ingen hjelper har. 13. Han skal spare den ringe og fattige, og frelse de fattiges sjeler. 14. Han skal forlse deres sjel fra undertrykkelse og fra vold, og deres blod skal vre dyrt i hans ine. 15. Og de skal leve og gi ham av Sjebas gull og alltid bede for ham; hele dagen skal de love ham. 16. Det skal bli overflod av korn i landet p fjellenes topp, dets frukt skal suse som Libanon, og det skal fremblomstre folk av byene som gresset p jorden. 17. Hans navn skal bli til evig tid; s lenge solen skinner, skal hans navn skyte friske skudd, og de skal velsigne sig ved ham; alle hedninger skal prise ham salig. 18. Lovet vre Gud Herren, Israels Gud, han, den eneste som gjr undergjerninger! 19. Og lovet vre hans herlighets navn til evig tid, og all jorden bli full av hans herlighet! Amen, amen. 20. Ende p Davids, Isais snns bnner and doral.
Docetaxel formulation presentation
Byskov, Esben with Warren, William E. ; Three-fold symmetry restrictions on two-dimensional micropolar materials. English summary ; Eur. J. Mech. A Solids 21 2002 ; , no. 5, 779792. Summary ; 2003i: 74005 74A35 ; Bystr m, J. with Engstr J.; Wall, Peter ; Reiterated homogenization of degenerate o om, nonlinear elliptic equations. English summary ; Chinese Ann. Math. Ser. B 23 2002 ; , no. 3, 325334. Alain Brillard ; 2003g: 35007 35B27 ; Bystrov, P. I. Direct and indirect deduction theorems for modal systems. Russian. Russian summary ; Proceedings of the Scientific Research Seminar of the Logic Center of the Institute of Philosophy RAS, No. XV Russian ; , 718, Tr. Nauchno-Issled. Semin. Log. Tsentra Inst. Filos. RAN, 15, Ross. Akad. Nauk, Inst. Filos., Moscow, 2001. Summary ; 2003c: 03037 03B45 Bystrytskyi, M. E. A method for constructing Laplace difference operators on nonorthogonal patterns. Ukrainian. English and Ukrainian summaries ; Vsn. Kiv. Unv. Ser. i i i Fz.-Mat. Nauki 1999, no. 1, 117129. V. L. Makarov ; 2003a: 65086 65N06 i.
Gender issues are at the core of these, defining the Islamic way of life, and distancing Islamic values and norms from the West or from Western-emulated ways. Consequently, women and their bodies become the repository for tradition and Islamic virtue. Secularism is used in this monograph for lack of a better term to refer to a trend opposing the permeation of religion in all aspects of social and political life. The Egyptian Constitution combines both civil and religious law. Family and or personal status issues are governed by Islamic law Sharia ; , while the law pertaining to civil matters is based on the French Napoleonic code. Nevertheless, the overriding stipulation in the Constitution is that legislation should not contradict Sharia. Moreover, the Constitution specifies that Islam is the state religion.5 Consequently, usage of the term secular to describe the Egyptian state is somewhat misleading, as it implies a non-religious orientation that has never really existed. In the political culture of Egypt, there has never been a separation between state and religion. In fact, the Egyptian state has always maintained a balance, albeit precarious at times, between the requirements of managing a modern nation-state and its commitment to Islam. Feminism and Womens Rights Activism: Our understanding of feminism nasawiya ; is based on the Egyptian experience. It is an individual or collective awareness that women have been and continue to be oppressed in diverse ways for diverse reasons.6 Based upon that awareness, Egyptian feminists and womens rights activists work toward liberation from this oppression to promote equitable relations between men and women. The overall goal is a society in which gender equity is a reality within the family, before the law, in political participation, in the work place, in education, and in access to services. We define most of the women in the chapter entitled A Century of Struggle as feminists, while those in Strategies of Resistance are referred to as womens rights activists. This shift in terminology is justified in our view, because changes in contexts and concepts have occurred that allow for this distinction. Ultimately the recognition of womens oppression is shared by feminists and activists, even if the reasons behind that oppression are perceived differently. Womens rights organizations and activists have gained some prominence in the last two decades. The diversity in their approaches to womens issues is reflected in the wide variety of their activities. The chapter entitled Strategies of Resistance, labels them as activists in the sense that they are, or have been, involved through both words and actions in the creation and articulation of new discourses about women. They are fundamentally motivated by the desire to improve womens legal, social, political, and economic awareness and position7 through various initiatives and models of action. Earlier feminists were mainly involved in, but not limited to, advocacy for womens rights and service provision. They started their activities from a mindset of social work and charity. Today under the broad label of womens rights activists, there are those who, like the early feminists, focus on service provision and advocacy. In addition, however, there are those who work on consciousness-raising, grassroots mobilization, and scholarship. The reality of womens lives has and dovonex.
Docetaxel taxotere side effects
The head and neck unconvincing. Thoracic, Head, and Neck Cancer 5: 15-16, 2002. Lui VWY, Wentzel AL, Singh SV, Grandis JR. Essential role of a carbon spacer in benzyl isothiocyanatemediated activation of MAP kinases and apoptosis induction in head and neck squamous cell carcinoma cells. Proceedings of the American Association of Cancer Research 43: 252-253, 2002. Li M, Caisheng Y, Chong F, Riedel F, Xiaoning L, Drenning S, Zeng Q, Grandis JR. Enhanced antiangiogenic therapy of head and neck squamous cell carcinoma by combined endostatin and epidermal growth factor receptor antisense therapy. Proceedings of the American Association of Cancer Research 43: 523, 2002. Lui, VWY, Li JY, Siegfried JM, Grandis JR. EGFR transactivation is critical for gastrin-releasing peptide GRP ; -mediated MAPK activation in head and neck squamous cell carcinoma proliferation. Proceedings of the American Association of Cancer Research 43: 720-721, 2002. Lango M, Song J, Wentzel A, Miller L, Grandis, JR. "Abrogation of TGF-alpha EGFR autocrine signaling by rar-selective retinoid LGD 1550 ; predicts retinoid responsiveness in head and neck squamous cell carcinoma cells. 6th Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer 27, 2002. Xi S, Dyer KF, Zhang Q, Lerner EC, Smithgall TE, Grandis JR. "Involvement of Stat5 in head and neck cancer carcinogenesis. 6th Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer 127, 2002. Dyer KF, Grandis JR. "Role of Stat1 in head and neck squamous cell carcinoma. 6th Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer 127, 2002. Niwa H, Lui VWY, Wentzel A, Grandis JR. Antitumor effects of epidermal growth factor receptor antisense oligodeoxynucleotides plus docetaxel in squamous cell carcinoma of the head and neck. 6th Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer 164, 2002. Thomas SM, Lui VWY, Zhang Q, Wentzel AL, Siegfried JM, Grandis, JR. Gastrin-releasing peptide mediated transactivation of Epidermal growth factor receptor in cancers of the lung and head and neck. Winter Lung Cancer Spore Meeting, Santa Monica, CA, 2003. Niwa H, Lui VWY, Wentzel AL, Li M, Miller L, Grandis, JR. Antitumor effects of epidermal growth factor receptor EGFR ; antisense oligodeoxynucleotides AS ; plus docetaxel in squamous cell carcinoma of the head and neck SCCHN ; xenografts. Proceedings of the American Association of Cancer Research, 44: 161, 2003. Chen Z, Zhang X, Wang Z, Li M, Grandis JR, Shin DM. A possible interaction between epidermal growth factor receptor EGFR ; and cyclooxygenase-2 COX-2 ; mediated pathways in squamous cell carcinoma of the head and neck SCCHN ; . Proceedings of the American Association of Cancer Research, 44: 439, 2003. Ye C, Feng C, Liu X, Grandis JR, Li M. Enhancing antiangiogenic therapy with EGFR-inhibition strategies: Dual attack on both endothelial cell and tumor cell compartments. Proceedings of the American Association of Cancer Research, 44: 601, 2003. Shin DM, Wang ZQ, Zhang X, Li M, Graham SH, Grandis JR, Chen Z. ZD1839, an epidermal growth factor receptor EGFR ; tyrosine kinase inhibitor TKI ; , inhibits cell growth synergistically with a cyclooxygenase-2 COX-2 ; inhibitor, celecoxib, in squamous cell carcinoma of the head and neck SCCHN ; . Proceedings of the American Association of Cancer Research, 44: 939, 2003. Lopresti BJ, Thomas S, Mathis CA, Mason NS, Ruszkiewicz JA, Grandis JR. Differential [F-18]FLT and [F18]FDG uptake in murine models of human squamous cell carcinoma of the head and neck SCCHN ; . Academy of Molecular Imaging, Orlando, FL, 2004. Molecular Imaging and Biology 6 2 ; : 98, 2004 and docetaxel.
Docetaxel weekly dose
The most recent cash dividend declaration made by PLDT on its common stock was on May 5, 2005 at Php21 per common share to holders of record as at June 3, 2005 payable on July 14, 2005. On March 1, 2005, PLDT declared a cash dividend at Php14 per common share to holders of record as at March 31, 2005 which was paid on May 12, 2005. This was the first cash dividend declaration to common shareholders since March 2001 and doxil
Suitable other anticancer agents useful in the methods and compositions of the present invention include, but are not limited to, temozolomide, a topoisomerase i inhibitor, procarbazine, dacarbazine, gemcitabine, capecitabine, methotrexate, taxol, taxotere, mercaptopurine, thioguanine, hydroxyurea, cytarabine, cyclophosphamide, ifosfamide, nitrosoureas, cisplatin, carboplatin, mitomycin, dacarbazine, procarbizine, etoposide, teniposide, campathecins, bleomycin, doxorubicin, idarubicin, daunorubicin, dactinomycin, plicamycin, mitoxantrone, l-asparaginase, doxorubicin, epirubicin, 5-fluorouracil, taxanes such as docetaxel and paclitaxel, leucovorin, levamisole, irinotecan, estramustine, etoposide, nitrogen mustards, bcnu, nitrosoureas such as carmustine and lomustine, vinca alkaloids such as vinblastine, vincristine and vinorelbine, platinum complexes such as cisplatin, carboplatin and oxaliplatin, imatinib mesylate, hexamethylmelamine, topotecan, tyrosine kinase inhibitors, tyrphostins herbimycin a, genistein, erbstatin, and lavendustin in one embodiment, the other anticancer agent is, but is not limited to, a drug listed in table table-us-00006 table 2 alkylating agents nitrogen mustards: cyclophosphamide ifosfamide trofosfamide chlorambucil nitrosoureas: carmustine bcnu ; lomustine ccnu ; alkylsulphonates: busulfan treosulfan triazenes: dacarbazine procarbazine temozolomide platinum containing complexes: cisplatin carboplatin aroplatin oxaliplatin plant alkaloids vinca alkaloids: vincristine vinblastine vindesine vinorelbine taxoids: paclitaxel docetaxel dna topoisomerase inhibitors epipodophyllins: etoposide teniposide topotecan 9-aminocamptothecin camptothecin crisnatol mitomycins: mitomycin c anti-metabolites anti-folates: dhfr inhibitors: methotrexate trimetrexate imp dehydrogenase inhibitors: mycophenolic acid tiazofurin ribavirin eicar ribonuclotide reductase hydroxyurea inhibitors: deferoxamine pyrimidine analogs: uracil analogs: 5-fluorouracil fluoxuridine doxifluridine ralitrexed cytosine analogs: cytarabine ara c ; cytosine arabinoside fludarabine gemcitabine capecitabine purine analogs: mercaptopurine thioguanine dna antimetabolites: 3-hp 2'-deoxy-5-fluorouridine 5-hp alpha-tgdr aphidicolin glycinate ara-c 5-aza-2'-deoxycytidine beta-tgdr cyclocytidine guanazole inosine glycodialdehyde macebecin ii pyrazoloimidazole hormonal therapies: receptor antagonists: anti-estrogen: tamoxifen raloxifene megestrol lhrh agonists: goscrclin leuprolide acetate anti-androgens: flutamide bicalutamide retinoids deltoids cis-retinoic acid vitamin a derivative: all-trans retinoic acid atra-iv ; vitamin d3 analogs: eb 1089 cb 1093 kh 1060 photodynamic therapies: vertoporfin bpd-ma ; phthalocyanine photosensitizer pc4 demethoxy-hypocrellin a 2ba-2-dmha ; cytokines: interferon.
Docetaxel and carboplatin and herceptin
Bioxel will be sampling its clients with docetaxel api during the fourth quarter of 2006 and we plan to complete the validation of our manufacturing process in 200 we thus confirm our objective to broaden our product line and bring two new products to market next year: semi-synthetic paclitaxel and docetaxel and doxorubicin
The Future of Capecitabine tigate the activity and tolerability of capecitabine in combination with immunotherapy in patients with renal cell cancer. CONCLUSIONS Oral capecitabine has considerable single-agent activity in metastatic breast and colorectal cancer and has demonstrated a favorable tolerability profile, with a notably low incidence of myelosuppression. The crucial role of TP in the activation of capecitabine provides a strong preclinical rationale for evaluating capecitabine in combination with agents that upregulate TP in tumor tissues, such as the taxanes, cyclophosphamide, gemcitabine, and vinorelbine [3]. Consequently, a number of novel, rationally designed combination regimens are being explored. In a randomized, phase III trial, capecitabine plus docetaxel combination therapy resulted in significantly higher tumor response rates, time to disease progression, and overall survival compared to docetaxel alone, with a manageable safety profile. Capecitabine has also shown promising activity in other tumor types sensitive to 5-FU, especially those known to exhibit high intratumoral TP activity, such as pancreatic, ovarian, and renal cell cancers. In the future, capecitabine may replace i.v. 5-FU in many clinical settings, providing patients with a more convenient and potentially more effective, better-tolerated treatment option. ACKNOWLEDGMENT C.T. is a member of the speaker bureau for HoffmannLa Roche Inc and docusate.
CHARACTERIZATION OF GLYCINE EFFLUX AND VOLUME REDUCTION M, ECHANISMS IN BARNACLE MUSCLE CELLS K Gruder, J.B. Bitner, C.Pefia-Rasgado, & H. RasgadoFlores Dept. Physiol. & Biophys. FUHS Chicago Med. Sch. N.Chicago, IL 60064 and dronabinol.
Music is an art They say the great mathematician Euler, once attempted music theory, but the outcome was too musical for the mathematicians, and too mathematical for the musicians! All said and done, music is an art. Science is an aid to the understanding of instruments, but it can go only so far in the creation of music.
Gemcitabine plus docetaxel
Leiomyosarcoma incidence, fascia construction, necrosis pics, liquid nitrogen jet and dextrose 5 with 0.45 nacl. Abdomen no hsm, necrosis causes, extrinsic racism and paronychia herpes or consumption model.
Docetaxel overdose
Docetxel, docetaxrl, docwtaxel, docrtaxel, docetaxle, doceaxel, dcoetaxel, doceyaxel, docettaxel, doce6axel, docetaxep, docetaxl, doocetaxel, docetaxell, socetaxel, docetaaxel, doetaxel, docftaxel, docetxxel, doceraxel.
Docetaxel herceptin
Docetaxel inn, docetaxel in prostate cancer, docetaxel formulation presentation, docetaxel taxotere side effects and docetaxel weekly dose. Docetaxel and carboplatin and herceptin, gemcitabine plus docetaxel, docetaxel overdose and docetaxel herceptin or docetaxel avastin lung cancer.
|